Nowadays, prostate cancer has become one of the most common malignant tumors [1]. Robot-assisted radical prostatectomy (RARP) is the standard treatment for localized prostate cancer [2]. Compared to traditional open and laparoscopic surgery, it has obvious advantages in tumor control, potency preservation,...
Androgen deprivation therapy plays an important role in the treatment of metastatic prostate cancer. In addition, new anti-androgen therapies, such as enzalutamide, abiraterone, apalutamide, and darolutamide, have been introduced for castration-resistant prostate cancer (CRPC) [1, 2, 3–4]. However,...
Prostate cancer is the second most diagnosed cancer in men globally and the fifth leading cause of death worldwide [1, 2]. Men of African ancestry suffer the most aggressive type of this cancer, leading to the highest mortality-to-incidence rate ratios globally compared with other ethnicities [3, 4]....
Prostate cancer (PCa) is the second most commonly diagnosed solid malignancy worldwide, with an ever-increasing incidence [1]. The definitive diagnosis of prostate cancer relies on histopathological verification through prostate biopsy. Currently, the indication for prostate biopsy is determined by prostate...
Most cancer treatments carry adverse effects that significantly impact patients' quality of life. The careful estimation of the risks and benefits associated with each treatment option is especially important for cancer patients who are being offered curative treatment. This is especially relevant for...